ATE103493T1 - Diagnose und behandlung chronischer ermuedungserscheinungen. - Google Patents

Diagnose und behandlung chronischer ermuedungserscheinungen.

Info

Publication number
ATE103493T1
ATE103493T1 AT89304188T AT89304188T ATE103493T1 AT E103493 T1 ATE103493 T1 AT E103493T1 AT 89304188 T AT89304188 T AT 89304188T AT 89304188 T AT89304188 T AT 89304188T AT E103493 T1 ATE103493 T1 AT E103493T1
Authority
AT
Austria
Prior art keywords
chronic fatigue
diagnosis
treatment
fatigue syndrome
levels
Prior art date
Application number
AT89304188T
Other languages
English (en)
Inventor
William A Carter
Original Assignee
Hem Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Pharma Corp filed Critical Hem Pharma Corp
Application granted granted Critical
Publication of ATE103493T1 publication Critical patent/ATE103493T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89304188T 1988-07-07 1989-04-26 Diagnose und behandlung chronischer ermuedungserscheinungen. ATE103493T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22076588A 1988-07-07 1988-07-07

Publications (1)

Publication Number Publication Date
ATE103493T1 true ATE103493T1 (de) 1994-04-15

Family

ID=22824871

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89304188T ATE103493T1 (de) 1988-07-07 1989-04-26 Diagnose und behandlung chronischer ermuedungserscheinungen.

Country Status (13)

Country Link
EP (1) EP0350151B1 (de)
CN (1) CN1056747C (de)
AT (1) ATE103493T1 (de)
AU (2) AU3781189A (de)
CA (1) CA1336685C (de)
DE (1) DE68914201T2 (de)
DK (1) DK332289A (de)
ES (2) ES2066847T3 (de)
IE (1) IE63927B1 (de)
IL (1) IL90875A (de)
NZ (1) NZ229849A (de)
PT (1) PT91094B (de)
ZA (1) ZA895143B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0495831B1 (de) * 1989-10-16 1997-01-15 Hem Pharmaceuticals Corp. Diagnose und behandlung von neuro-cognitiven störungen assoziiert mit systemisch-immunologischer fehlfunktion
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
US5776690A (en) * 1996-10-07 1998-07-07 Vojdani; Aristo Detection of chronic fatigue syndrome by decreased levels of RNase L inhibitor mRNA
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
KR20010042069A (ko) 1998-03-20 2001-05-25 베니텍 오스트레일리아 리미티드 유전자 발현 조절방법
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP2314700A1 (de) 1999-01-28 2011-04-27 Medical College of Georgia Research Institute, Inc Zusammensetzung und Verfahren zur in vivo und in vitro Abschwächung der Genexpression mittels dobbelsträngiger RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US20020132257A1 (en) 2001-01-31 2002-09-19 Tony Giordano Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
US20120004290A1 (en) * 2009-03-13 2012-01-05 David Strayer Treating chronic fatigue syndrome and prolonged qt interval
EP3652542A1 (de) * 2017-07-14 2020-05-20 Protea Biopharma N.V. Verfahren und vorrichtungen zur diagnose und / oder behandlung einer ermüdungserkrankung
CN113194963A (zh) * 2018-12-13 2021-07-30 Aim免疫科技有限公司 提高肌痛性脑脊髓炎患者运动耐量的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
PH30882A (en) * 1987-03-03 1997-12-23 Hem Res Inc Activated Rnase L as a maker for viral infections.
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
EP0306347B1 (de) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnose von Mangelzuständen doppelsträngiger RNS

Also Published As

Publication number Publication date
AU684288B2 (en) 1997-12-11
IE892180L (en) 1990-01-07
CN1039722A (zh) 1990-02-21
DK332289D0 (da) 1989-07-04
NZ229849A (en) 1997-07-27
AU3781189A (en) 1990-01-11
EP0350151A2 (de) 1990-01-10
AU6883694A (en) 1994-11-24
EP0350151A3 (en) 1990-10-03
ES2018903A6 (es) 1991-05-16
CN1056747C (zh) 2000-09-27
PT91094B (pt) 1995-01-31
DK332289A (da) 1990-01-08
ES2066847T3 (es) 1995-03-16
IL90875A0 (en) 1990-02-09
IL90875A (en) 1994-04-12
DE68914201T2 (de) 1994-07-14
EP0350151B1 (de) 1994-03-30
IE63927B1 (en) 1995-06-28
PT91094A (pt) 1990-02-08
ZA895143B (en) 1991-04-24
DE68914201D1 (de) 1994-05-05
CA1336685C (en) 1995-08-15

Similar Documents

Publication Publication Date Title
Shepherd et al. Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association
DE68914201D1 (de) Diagnose und Behandlung chronischer Ermüdungserscheinungen.
Rosin et al. Clinical features of accidental hypothermia, with some observations on thyroid function
Berman et al. Eating attitudes in seasonal affective disorder and bulimia nervosa
Jung et al. Paroxysmal choreoathetosis: report of Chinese cases
Dawson et al. Diagnostic utility of autonomic measures for major depressive disorders
Ostfeld et al. Personality factors and pressor mechanisms in renal and essential hypertension
Murphy et al. Persisting cholinergic erythema: a variant of cholinergic urticaria
Michel Liet et al. Effects of hydroxyethyl starch on cardiac output in hypotensive neonates: A comparison with isotonic saline and 5% albumin
ATE147629T1 (de) Diagnose und behandlung von neuro-cognitiven störungen assoziiert mit systemisch- immunologischer fehlfunktion
Pohl et al. Lactate and isoproterenol infusions in bulimic patients
Llopis THE AXIAL SYNDROME COMMON TO ALL PSYCHOSES: Part 2
Cruz‐Montecinos et al. Neuromuscular control of masticatory muscles in people with intellectual disability, middle‐aged adults and older adults
Stewart Discussion On Causation And Symptomatology Of Multiple Neuritis
Banov Paroxysmal cold hemoglobinuria: Apparent remission after splenectomy
Allen Evaluation and Management of RLS and PLMD
Sato et al. Characteristics of Sleep and Autonomic Activity in Active Older Adults Based on Metabolic Age: A Case Report
Petiot et al. Individual differences in cardiovascular responses to intermittent noise in human females
Padilla et al. Human Responses to Cancer
Hening Restless Legs Syndrome and Periodic Limb Movements Disorder in Adults
Musso et al. P-169: Very low reduction of daily sodium intake: ABPM evaluation of BP decrease in 200 treated hypertensive patients
Kuznetsova et al. Study of the changes in carbohydrate metabolism as a diagnostic test of acute hypothalamic syndrome in severe cranio-cerebral trauma
HILL et al. 422 SEPT. 12, 1959 THE SECTIONS BRMA u
Corwin et al. Treatment of the Total Organism in Schizophrenic Patients
Granville A PLEA FOR THE CLASSIFICATION AND DETAILED STUDY OF MENTAL AND SENSORY CAUSES, OR FORMS, OF SLEEPLESSNESS.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee